Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial [Phase 1]

View source ↗

Summary

Phase 1 feasibility trial evaluating repurposed drugs for thyroid carcinoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Thyroid Cancer Stage IV, Anaplastic Thyroid Cancer | Phase 1 | Status: NOT_YET_RECRUITING